UK Pen Needles Market (2024-2029)
The UK Pen Needles Market was valued at $100.46 Million in 2024 and projected to reach to $166.32 Million by 2029, representing a compound annual growth rate of 8.8%. The UK pen needles market is positioned for sustained growth through 2029, supported by increasing diabetes diagnoses and NHS commitment to improving patient outcomes.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK Pen Needles Market Trends and Insights
- The UK market is driven by rising diabetes prevalence, increased adoption of injectable therapies, and growing patient preference for convenient self-administration devices.
- In the UK, healthcare modernization and NHS initiatives supporting diabetes management are accelerating demand for advanced pen needle technologies. The UK pen needles market benefits from strong regulatory frameworks and established distribution networks across the National Health Service and private healthcare sectors.
- UK manufacturers and suppliers are investing in product innovation, including ultra-thin needles and safety-engineered designs, to meet evolving clinical and patient needs.
- Between 2024 and 2029, the UK market is expected to capture significant value as awareness campaigns and improved reimbursement policies expand access to premium pen needle products across the country..
Key Market Statistics
- CAGR (2024-2029) 8.8% CAGR
- Market Size, 2024 ~USD 100.46 Million
- Forecast, 2029 ~USD 166.32 Million
- Country UK
UK Pen Needles Market Overview
Market Valuation :
The UK pen needles market is valued at $100.46 million in 2024, with a projected CAGR of 8.8% through 2029, reaching $166.32 million by forecast end.
Diabetes Prevalence Driver :
Rising diabetes prevalence across the UK population is a primary growth catalyst, with increasing numbers of patients requiring injectable insulin and GLP-1 therapies for disease management.
NHS Support & Healthcare Modernization :
NHS initiatives promoting diabetes management and healthcare modernization are accelerating adoption of convenient self-administration devices, particularly among Type 2 diabetes patients.
Patient Preference Shift :
Growing patient preference for user-friendly, convenient self-injection devices is driving demand for advanced pen needle solutions with improved safety features and ease of use.
UK Pen Needles Market Dynamics
- The shift towards injectable therapies, including newer GLP-1 medications for weight management, is expanding the addressable patient population beyond traditional insulin users.
- Healthcare providers and pharmaceutical companies are investing in patient education and device accessibility, further propelling market expansion.
- Technological innovations in needle design and safety mechanisms are enhancing user experience and compliance rates across UK healthcare settings..
Related Ecosystem
Drug Delivery Devices
- Disposable Autoinjectors
- Reusable Autoinjectors
- Insulin Pumps
- Pen Injectors
- Transdermal Patches
- Novo nordisk a/s
- Becton, Dickinson and Company
- Terumo Corporation
- Medtronic plc
- Nipro Corporation
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- The UK pen needles market is valued at $100.46 million in 2024 and is projected to reach $166.32 million by 2029, representing an 8.8% CAGR.
- Rising diabetes prevalence and NHS-backed diabetes management initiatives are primary growth drivers in the UK market.
- UK healthcare providers and patients increasingly prefer advanced pen needle technologies offering safety features and improved comfort.
- Strong regulatory oversight and established NHS distribution channels position the UK as a mature, high-value market for pen needle manufacturers.
Pen Needles Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | SAFETY PEN NEEDLES (Type) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 9.2% from 2024 to 2029 |
| Largest Segment | STANDARD PEN NEEDLES (Type) |
| Market Size Base Year (Billions) | ~USD 1.82 (2024) |
| Revenue Forecast (Billions) | ~USD 3.08 (2029) |
| Segments Covered | Type, Length, Application, Mode Of Purchase, Care Setting |
UK Pen Needles Market Report Segmentation
5 segment dimensions are covered across the global market.
By Type
- Safety Pen Needles
- Standard Pen Needles
By Length
- 10Mm
- 12Mm
- 4Mm
- 5Mm
- 6Mm
- 8Mm
By Application
- Glp-1 Therapy
- Growth Hormone Therapy
- Insulin Therapy
- Osteoporosis
- Other Applications
By Mode Of Purchase
- Online Purchase
- Otc Purchase
- Other Modes Of Purchase
- Prescription-Based Purchase
By Care Setting
- Home Care Settings
- Hospitals & Clinics
- Hospitals And Clinics
- Other End Users
UK: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| GLP-1 THERAPY | 5.07 | 5.25 | 5.57 | 5.99 | 6.45 | 7.56 | 8.22 | 8.97 | 8.3 |
| GROWTH HORMONE THERAPY | 1.45 | 1.44 | 1.47 | 1.52 | 1.58 | 1.71 | 1.79 | 1.88 | 4.1 |
| INSULIN THERAPY | 66.5 | 69.52 | 74.51 | 80.85 | 87.95 | 105.01 | 115.31 | 127.06 | 9.3 |
| OSTEOPOROSIS | 4.06 | 4.19 | 4.42 | 4.73 | 5.08 | 5.9 | 6.39 | 6.94 | 7.8 |
| OTHER APPLICATIONS | 6.74 | 6.84 | 7.11 | 7.49 | 7.91 | 8.9 | 9.48 | 10.14 | 6.1 |
| TOTAL | 83.82 | 87.24 | 93.09 | 100.59 | 108.96 | 129.07 | 141.18 | 154.99 | 8.9 |
Target Audience
- Medical Device Manufacturers : Manufacturers need UK-specific market data to develop localized product strategies, understand NHS procurement processes, and identify partnership opportunities with UK distributors and healthcare providers.
- Pharmaceutical Companies : Pharma firms require insights into UK pen needle adoption rates and patient preferences to optimize injectable therapy commercialization and support healthcare provider relationships.
- Healthcare Providers & NHS Trusts : NHS organizations need market intelligence to inform procurement decisions, budget planning, and patient care protocols aligned with diabetes management modernization initiatives.
- Distributors & Retailers : UK distributors and pharmacy retailers require market forecasts and competitive analysis to optimize inventory management, supplier negotiations, and retail positioning strategies.
- Investment & Private Equity Firms : Investors need comprehensive UK market analysis to evaluate acquisition targets, assess growth potential, and make informed funding decisions in the medical device and healthcare sectors.
Key Companies in the UK Pen Needles Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Injectable and infusion-based delivery in LTAC hospitals,Oral drug administration in inpatient rehabilitation facilities,Contract rehabilitation and outpatient-related drug administration support, |
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automated manufacturing and assembly systems,Lifecycle services and digital/connected factory solutions,Contract manufacturing and value-added integration, |
| ALLERGAN PLC | Ireland | Private Company | Medical Aesthetics & Dermatology,Eye Care,Neuroscience & CNS, |
| CONSORT MEDICAL | United Kingdom | Private Company | Inhalation delivery devices,Injectable and autoinjector devices,Nasal and other specialty devices, |
| HENRY SCHEIN | United States | Public Company | Global Distribution & Value-Added Services,Global Specialty Products,Global Technology, |
| EMBECTA CORP. | United States | Public Company | Pen needles,Syringes,Safety injection devices, |
| NOVO NORDISK A/S | Denmark | Public Company | GLP-1 for Diabetes (injectable and oral),Obesity Care (GLP-1, including Wegovy pill),Insulin and Smart Pens (NovoPen 6, Echo Plus, needles), |
| YPSOMED | Switzerland | Public Company | Pen injectors,Auto-injectors,Wearable injectors and patch pumps, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| NIPRO | Japan | Public Company | Dialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceutical-related (generics, kits, CDMO for injectables and oral drugs), |
| ARKRAY, INC. | Japan | Private Company | Diabetes testing & blood glucose monitoring,Urinalysis,Immunodiagnostics, |
| HTL-STREFA | Poland | Private Company | Safety lancets for professional capillary sampling,Personal lancets for home blood glucose monitoring,Pen needles for diabetes therapy, |
| BERPU MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | Regular insulin pen needles,Safety insulin pen needles and pens,Hypodermic and hypo-dermal needles, |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates with 64,200 employees. The company provides healthcare services and related solutions across the United States.
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ALLERGAN PLC
Allergan PLC is an Ireland-based private company founded in 1983 with 17,400 employees. The company operates in the pharmaceutical and medical aesthetics sectors.
CONSORT MEDICAL
Consort Medical is a United Kingdom-based private company founded in 1938 with 2,000 employees. The company provides medical device and pharmaceutical delivery solutions.
HENRY SCHEIN
Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to medical, dental, and veterinary professionals.
EMBECTA CORP.
Embecta Corp. is a United States-based public company founded in 1924 with 1,850 employees. The company manufactures and distributes diabetes care and medical devices.
NOVO NORDISK A/S
Novo Nordisk A/S is a Denmark-based public company founded in 1923 with 67,900 employees. The company is a global pharmaceutical company specializing in diabetes, obesity, and other chronic diseases.
YPSOMED
Ypsomed is a Switzerland-based public company founded in 1984 with 2,025 employees. The company develops and manufactures injection and infusion systems for diabetes and other therapeutic areas.
TERUMO CORPORATION
Terumo Corporation is a Japan-based public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices, blood products, and pharmaceutical solutions globally.
NIPRO
Nipro is a Japan-based public company founded in 1947 with 38,593 employees. The company manufactures and supplies medical devices, pharmaceuticals, and healthcare products worldwide.
ARKRAY, INC.
Arkray, Inc. is a Japan-based private company founded in 1960 with 566 employees. The company manufactures diagnostic and medical devices for healthcare applications.
HTL-STREFA
HTL-Strefa is a Poland-based private company founded in 2000. The company manufactures medical devices and related healthcare products.
BERPU MEDICAL TECHNOLOGY CO., LTD.
Berpu Medical Technology Co., Ltd. is a China-based private company founded in 2000. The company manufactures medical devices and related healthcare solutions.
Reasons to Buy this Report
- UK-Specific Market Sizing : Obtain precise market valuation and forecasts tailored to the UK market, enabling accurate budget allocation and revenue projections for UK operations and expansion strategies.
- NHS Policy & Regulatory Insights : Understand NHS procurement requirements, reimbursement pathways, and regulatory compliance standards specific to the UK healthcare system for successful market entry and partnerships.
- Competitive Landscape Analysis : Identify key competitors, market share distribution, and differentiation opportunities within the UK pen needles segment to inform product positioning and go-to-market strategies.
- Patient Demographics & Segmentation : Access detailed UK patient segmentation data including diabetes prevalence by region, age groups, and therapy types to optimize targeting and distribution channel selection.
- Growth Opportunity Identification : Discover emerging opportunities in the UK market including GLP-1 adoption trends, NHS modernization initiatives, and unmet patient needs to guide product development priorities.
Frequently asked questions
What is the current size of the UK pen needles market?
The UK pen needles market was valued at $100.46 million in 2024 and is expected to grow to $166.32 million by 2029.
What is the projected growth rate for the UK pen needles market?
The UK pen needles market is projected to grow at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2029.
What factors are driving growth in the UK pen needles market?
Key drivers include rising diabetes prevalence in the UK, increased adoption of injectable therapies, NHS modernization initiatives, and growing patient preference for convenient self-administration devices.
How does the UK pen needles market compare to other European markets?
The UK represents a mature, high-value segment within Europe, characterized by strong regulatory frameworks, established NHS distribution networks, and significant investment in advanced pen needle technologies.
What product innovations are shaping the UK pen needles market?
UK manufacturers are focusing on ultra-thin needle designs, safety-engineered features, and improved comfort profiles to meet evolving clinical standards and patient preferences.
RESEARCH METHODOLOGY
This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the pen needles market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the pen needles market. Primary sources from the demand side included hospitals, clinics, researchers, lab technicians, purchase managers etc, and stakeholders in corporate & government bodies.
A breakdown of the primary respondents for pen needles market (supply side) market is provided below:
Note 1: Companies are classified into tiers based on their total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
Note 2: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 3: Other primaries include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size for pen needles market was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for pen needles market was calculated using data from three distinct sources, as will be discussed below:
Data Triangulation
The entire market was split up into five segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments.
Approach to derive the market size and estimate market growth.
Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of pen needles. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
A pen needle is a hollow needle entrenched in a plastic hub and attached to injectable pens. Pen needles are available in a wide range of lengths and diameters and can be used by healthcare professionals and patients to deliver injectable medications into the patient’s body. Pen needles are electro-polished for smooth, thin, and fine-point tips and provide comfort and ease in penetration; they serve as an alternative drug delivery technique to the traditional method of injecting drugs.
Stakeholders
- Manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Original equipment manufacturing companies
- Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Healthcare service providers
- Teaching hospitals and academic medical centers
- Health insurance players
- Government bodies/municipal corporations
- Regulatory bodies
- Business research and consulting service providers
- Authorities framing reimbursement policies for pen needles
- Venture capitalists
- Market research and consulting firms
Report Objectives
- To define, describe, and forecast the pen needles market based on type, length, application, mode of purchase, setting and region.
- To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall pen needles market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the pen needles market in North America, Europe, the Asia Pacific, Latin America, Middle East & Africa and GCC Countries
- To profile the key players and comprehensively analyze their market shares and core competencies in the pen needles market
- To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, product launches, agreements, and other developments in the pen needles market
- To benchmark players within the pen needles market using the Company Evaluation Quadrant framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings.
Get the Full Pen Needles Market Report
Full forecast, segment splits, and company analysis for all Pen Needles Market.
- Canada Pen Needles Market
- US Pen Needles Market
- Germany Pen Needles Market
- France Pen Needles Market
- Italy Pen Needles Market
- Spain Pen Needles Market
- Japan Pen Needles Market
- China Pen Needles Market
- India Pen Needles Market
- South Korea Pen Needles Market
- Brazil Pen Needles Market
- Mexico Pen Needles Market
- Argentina Pen Needles Market
- GCC Countries Pen Needles Market
- Rest Of Europe Pen Needles Market
- Rest Of Asia Pacific Pen Needles Market
- Southeast Asia Pen Needles Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
